REG - Rentokil Initial PLC - Notice of Management Presentation

Rentokil InitialAnnouncement

27/02/2023 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230227:nRSa0422Ra&default-theme=true

RNS Number : 0422R  Rentokil Initial PLC  27 February 2023

Notice of Management Presentation

Rentokil Initial plc (the "Company") will announce its Preliminary Results for
the year ended 31 December 2022 on Thursday, 16 March 2023. A management
presentation and Q&A for investors and analysts will be held on 16 March
from 9.15am to approximately 11.00am (GMT) in the Bartholomew Suite Conference
Room, The Leonardo Royal Hotel, 45 Prescot Street, London E1 8GP.

The presentation and Q&A will be hosted by Andy Ransom, CEO, Stuart
Ingall-Tombs, CFO and Brett Ponton, President and CEO North America. In
addition to a discussion of the Preliminary Results, the management team will
also provide an update on the Terminix integration process, the Pest Control
market and the Company's North America growth strategy.

 

To register attendance please email investor@rentokil-initial.com. The event
will also be available via a live audio webcast. Dial-in details will be
provided on the Company's IR website
(https://www.rentokil-initial.com/investors.aspx
(https://www.rentokil-initial.com/investors.aspx) ). A recording will be made
available following the conclusion of the presentation.

 

 

 

 

For further information please contact:

 

Rentokil Initial plc

Peter Russell, Director of IR

07795 166506

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSEUFMLEDSESE